Amrutanjan Health Care Live BSE/NSE | Amrutanjan Health Care Fundamenta data | Amrutanjan Health Care Balance sheet | Amrutanjan Health Care Quarterly Results | Amrutanjan Health Care Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,191.88
37.00
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,155.55
0.52%
7.19

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.72
7.24
5.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.58
-0.47
1.76

PAT CAGR (%)

10 Years
5 Years
3 Years

8.91
2.27
7.89

P:E (Median)

8 Years
5 Years
3 Years

35.19
39.95
43.53

P:BV (Average)

8 Years
5 Years
3 Years

7.29
7.29
7.29

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.15
23.20
25.23

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 47 45 5% 59 86 -31% 83 70 18% 75 62 21%
Expenses 39 46 -15% 50 68 -26% 71 63 13% 63 53 19%
EBITDA 8 -2 - 9 18 -51% 12 7 71% 12 9 32%
EBIDTM 16% -4% 0% 21% 14% 10% 15% 14%
Other Income 2 2 31% 3 3 -1% 2 2 41% 2 2 21%
Interest 0 0 0% 0 0 133% 0 0 0 0 0 25%
Depreciation 1 1 12% 1 1 24% 1 1 51% 1 1 57%
PBT 9 -1 - 11 20 -47% 13 8 67% 12 9 28%
Tax 2 0 - 3 6 -54% 3 2 53% 4 3 33%
PAT 6 -1 - 8 14 -45% 9 6 72% 8 7 26%
PATM 14% -2% 3% 17% 11% 8% 11% 11%
EPS 2.20 -0.24 - 2.70 4.87 -45% 3.25 1.89 72% 2.88 2.28 26%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 264 261 253 222 212 184 163 139 135 135 103 Net Sales Growth 0% 3% 14% 5% 15% 13% 18% 3% 0% 31% Cost Of Goods Sold 591 117 119 97 87 37 32 29 34 33 27 Gross Profit -327 144 134 125 124 147 131 110 101 102 76 GP Margin -124% 55% 53% 56% 59% 80% 80% 79% 75% 75% 74% Total Expenditure 224 231 222 194 182 153 139 116 116 114 90 Power & Fuel Cost - 2 2 2 2 2 2 1 2 1 1 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% Employee Cost - 39 33 34 30 28 25 22 20 18 16 % Of Sales - 15% 13% 15% 14% 15% 15% 16% 15% 13% 15% Manufacturing Exp. - 15 14 15 5 35 34 30 29 29 18 % Of Sales - 6% 6% 7% 3% 19% 21% 21% 22% 21% 18% General & Admin Exp. - 10 11 11 12 10 9 8 7 7 7 % Of Sales - 4% 4% 5% 6% 6% 6% 6% 5% 5% 6% Selling & Distn. Exp. - 44 41 32 43 40 36 24 24 25 20 % Of Sales - 17% 16% 14% 20% 22% 22% 17% 18% 18% 19% Miscellaneous Exp. - 4 3 2 3 1 1 2 1 1 20 % Of Sales - 2% 1% 1% 1% 1% 1% 1% 1% 1% 1% EBITDA 40 31 31 28 30 32 25 22 19 21 14 EBITDA Margin 15% 12% 12% 13% 14% 17% 15% 16% 14% 15% 13% Other Income 9 8 7 8 7 6 5 4 4 4 5 Interest 0 0 0 0 1 0 1 2 2 3 1 Depreciation 4 4 3 3 3 3 2 3 3 3 2 PBT 44 34 35 33 34 35 26 21 18 19 16 Tax 12 9 10 13 12 12 9 7 6 5 5 Tax Rate 27% 27% 29% 39% 35% 35% 35% 32% 32% 29% 33% PAT 32 25 25 20 22 22 17 15 12 13 11 PAT before Minority Interest 32 25 25 20 22 22 17 15 12 13 11 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 12% 10% 10% 9% 10% 12% 10% 10% 9% 10% 10% PAT Growth 25% 2% 23% -8% -3% 31% 18% 20% -8% 24% EPS 11.03 8.59 8.39 6.84 7.47 7.68 5.86 4.97 4.15 4.53 3.66

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

264

261

253

222

212

184

163

139

135

103

Net Sales Growth

14%

15%

13%

18%

31%

Cost Of Goods Sold

591

117

119

Gross Profit

-327

144

134

125

124

147

131

110

101

102

GP Margin

-124%

55%

53%

56%

59%

80%

79%

75%

74%

Total Expenditure

224

231

222

194

182

153

139

116

114

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

15%

13%

15%

14%

15%

16%

15%

13%

15%

Manufacturing Exp.

% Of Sales

19%

21%

22%

21%

18%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

17%

16%

14%

20%

22%

17%

18%

19%

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

15%

12%

13%

14%

17%

15%

16%

14%

15%

13%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

27%

29%

39%

35%

32%

29%

33%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

12%

10%

12%

10%

PAT Growth

25%

23%

-8%

-3%

31%

18%

20%

-8%

24%

EPS

11.03

8.59

8.39

6.84

7.47

7.68

5.86

4.97

4.15

4.53

3.66

Description TTM Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08 Mar 07
Net Sales - 187 167 142 138 143 105 90 91 75 72 Net Sales Growth - 12% 18% 3% -4% 36% 17% -1% 22% 3% Cost Of Goods Sold - 67 63 57 60 65 43 16 23 18 14 Gross Profit - 120 104 85 77 78 62 74 68 56 58 GP Margin - 64% 62% 60% 56% 55% 59% 82% 75% 75% 80% Total Expenditure - 156 143 121 120 125 92 77 78 63 57 Power & Fuel Cost - 2 2 2 2 2 1 1 1 1 1 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 2% 1% Employee Cost - 29 26 23 21 19 16 13 10 9 8 % Of Sales - 15% 16% 16% 15% 14% 15% 15% 11% 12% 11% Manufacturing Exp. - 7 6 5 5 5 4 20 18 15 16 % Of Sales - 4% 4% 4% 4% 4% 4% 22% 20% 20% 22% General & Admin Exp. - 10 9 9 8 8 7 8 7 6 5 % Of Sales - 6% 6% 6% 6% 5% 6% 8% 8% 8% 6% Selling & Distn. Exp. - 40 36 24 24 25 20 17 17 13 12 % Of Sales - 21% 21% 17% 17% 17% 19% 19% 19% 17% 16% Miscellaneous Exp. - 1 1 2 1 1 1 3 2 1 12 % Of Sales - 1% 1% 1% 1% 1% 1% 4% 2% 2% 1% EBITDA - 31 24 21 17 18 13 12 13 11 16 EBITDA Margin - 16% 14% 15% 13% 13% 12% 14% 14% 15% 22% Other Income - 6 4 4 4 5 5 6 7 0 1 Interest - 0 1 2 2 3 1 0 0 1 1 Depreciation - 3 3 4 4 4 2 1 2 2 2 PBT - 33 24 19 15 16 16 17 18 9 14 Tax - 12 9 7 5 6 5 7 7 4 5 Tax Rate - 37% 38% 36% 35% 39% 34% 38% 7% 42% 46% PAT - 21 15 12 10 10 10 11 92 5 6 PAT before Minority Interest - 21 15 12 10 10 10 11 92 5 6 Minority Interest - 0 0 0 0 0 0 0 0 0 0 PAT Margin - 11% 9% 9% 7% 7% 10% 13% 102% 7% 8% PAT Growth - 38% 20% 23% 5% -6% -11% -88% 1,737% -15% EPS - 7.05 5.10 4.26 3.47 3.30 3.50 3.93 31.64 1.72 2.02

Description

TTM

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Mar 08

Mar 07

Net Sales

187

167

142

138

143

105

Net Sales Growth

12%

18%

-4%

36%

17%

-1%

22%

Cost Of Goods Sold

Gross Profit

120

104

GP Margin

64%

62%

60%

56%

55%

59%

82%

75%

80%

Total Expenditure

156

143

121

120

125

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

15%

16%

15%

14%

15%

11%

12%

11%

Manufacturing Exp.

% Of Sales

22%

20%

22%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

21%

17%

19%

17%

16%

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

16%

14%

15%

13%

12%

14%

15%

22%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

37%

38%

36%

35%

39%

34%

38%

42%

46%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

11%

10%

13%

102%

PAT Growth

38%

20%

23%

-6%

-11%

-88%

1,737%

-15%

EPS

7.05

5.10

4.26

3.47

3.30

3.50

3.93

31.64

1.72

2.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 159 146 129 116 120 105 97 88 81 103 Share Capital 3 3 3 3 3 3 3 3 3 3 Total Reserves 156 143 126 113 118 102 94 85 78 100 Non-Current Liabilities 2 2 1 1 3 2 3 3 9 8 Secured Loans 0 0 0 0 0 0 0 0 6 3 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 6 5 5 4 1 1 1 0 0 0 Current Liabilities 39 36 32 32 25 23 24 35 34 43 Trade Payables 31 30 26 25 9 7 7 9 8 6 Other Current Liabilities 6 4 3 4 14 10 7 9 7 10 Short Term Borrowings 0 0 0 2 0 0 6 13 14 22 Short Term Provisions 2 2 2 1 2 6 5 5 5 4 Total Liabilities 201 183 162 149 149 130 124 127 124 153 Net Block 26 26 28 27 22 13 15 17 19 30 Gross Block 40 35 33 30 39 26 32 32 31 40 Accumulated Depreciation 13 9 6 3 16 13 18 15 12 10 Non Current Assets 75 44 41 41 54 52 51 69 74 86 Capital Work in Progress 0 0 0 1 1 4 1 1 1 0 Non Current Investment 18 16 8 7 10 14 14 30 31 52 Long Term Loans & Adv. 3 2 2 5 21 21 20 19 22 4 Other Non Current Assets 28 0 4 0 0 0 2 2 2 0 Current Assets 126 140 121 108 95 79 73 58 50 67 Current Investments 0 2 0 2 0 0 0 0 4 17 Inventories 24 15 10 10 8 7 7 7 9 9 Sundry Debtors 26 33 28 29 26 26 24 27 13 12 Cash & Bank 36 81 73 31 48 38 35 15 15 20 Other Current Assets 39 3 7 1 13 7 8 8 9 10 Short Term Loans & Adv. 36 6 3 35 9 4 6 7 8 8 Net Current Assets 87 104 89 76 69 56 49 22 16 24 Total Assets 201 183 162 149 149 130 124 127 124 153

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

159

146

129

116

120

105

103

Share Capital

Total Reserves

156

143

126

113

118

102

100

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

201

183

162

149

130

124

127

124

153

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

126

140

121

108

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

104

Total Assets

201

183

162

149

130

124

127

124

153

Description Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08 Mar 07
Shareholder's Funds 109 95 89 82 77 101 97 93 26 23 Share Capital 3 3 3 3 3 3 3 3 3 3 Total Reserves 106 92 86 79 74 98 94 90 23 20 Non-Current Liabilities 4 3 4 4 10 8 4 4 12 10 Secured Loans 0 0 0 0 6 4 1 0 6 8 Unsecured Loans 0 0 0 0 0 0 0 0 2 0 Long Term Provisions 1 1 1 0 0 0 0 0 0 0 Current Liabilities 28 26 27 38 37 47 18 14 10 8 Trade Payables 9 8 7 9 10 7 12 7 6 6 Other Current Liabilities 14 10 7 9 7 10 2 1 2 2 Short Term Borrowings 2 2 8 15 14 26 0 0 0 0 Short Term Provisions 2 6 5 5 5 4 4 5 1 1 Total Liabilities 140 124 120 124 124 157 118 111 48 41 Net Block 29 24 27 30 33 52 16 16 20 13 Gross Block 48 40 47 47 46 64 25 30 40 26 Accumulated Depreciation 20 16 20 17 13 12 9 14 20 13 Non Current Assets 40 41 42 61 64 83 68 19 23 16 Capital Work in Progress 1 4 1 1 1 0 7 2 3 3 Non Current Investment 9 9 9 25 25 26 46 0 0 0 Long Term Loans & Adv. 1 4 4 3 3 3 0 0 0 0 Other Non Current Assets 0 0 2 2 2 2 0 0 0 0 Current Assets 100 83 78 63 61 74 50 92 25 26 Current Investments 0 0 0 0 4 17 0 0 0 0 Inventories 9 9 9 10 13 10 7 5 9 9 Sundry Debtors 28 28 25 28 18 12 10 13 8 5 Cash & Bank 48 38 35 15 15 24 24 68 3 8 Other Current Assets 16 3 2 2 11 11 8 6 5 4 Short Term Loans & Adv. 12 6 8 8 10 9 7 5 5 4 Net Current Assets 73 57 51 25 24 27 33 78 16 18 Total Assets 140 124 120 124 124 157 118 111 48 41

Description

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Mar 08

Mar 07

Shareholder's Funds

109

101

Share Capital

Total Reserves

106

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

140

124

120

124

157

118

111

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

100

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

140

124

120

124

157

118

111

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 18 21 19 8 21 19 18 8 13 6 PBT 34 35 33 34 35 26 21 18 19 16 Adjustment -1 -3 -4 0 -2 -1 3 3 2 -1 Changes in Working Capital -4 -1 0 -11 1 3 1 -6 -3 -4 Cash after chg. in Working capital 29 31 30 22 33 28 25 14 19 10 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -11 -10 -11 -14 -11 -9 -7 -6 -5 -4 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -14 -11 -8 0 1 -5 16 11 4 -30 Net Fixed Assets -5 -1 -3 9 -10 4 -1 -1 9 -10 Net Investments -1 -10 2 0 4 0 16 4 34 -22 Others -8 0 -7 -9 7 -9 1 7 -39 2 Cash from Financing Activity -12 -7 -9 -5 -11 -12 -14 -17 -27 20 Net Cash Inflow / Outflow -7 3 2 3 12 2 20 2 -9 -4 Opening Cash & Equivalents 15 11 10 22 31 29 9 7 24 24 Closing Cash & Equivalent 7 15 11 25 42 31 29 9 15 20

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

PBT

Adjustment

-1

-3

-4

-2

-1

Changes in Working Capital

-4

-1

-11

-6

-3

-4

Cash after chg. in Working capital

Interest Paid

Tax Paid

-11

-10

-11

-14

-11

-9

-7

-6

-5

-4

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-14

-11

-8

-5

-30

Net Fixed Assets

-5

-1

-3

-10

-1

-10

Net Investments

-1

-10

-22

Others

-8

-7

-9

-39

Cash from Financing Activity

-12

-7

-9

-5

-11

-12

-14

-17

-27

Net Cash Inflow / Outflow

-7

-9

-4

Opening Cash & Equivalents

Closing Cash & Equivalent

Description Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08 Mar 07
Cash From Operating Activity 21 18 17 9 4 6 11 6 5 11 PBT 33 24 19 15 16 16 19 18 9 14 Adjustment -1 0 4 3 3 -1 -2 -5 3 1 Changes in Working Capital 1 3 2 -4 -10 -4 3 -1 -5 2 Cash after chg. in Working capital 32 28 25 14 9 10 20 12 7 18 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -11 -9 -7 -6 -5 -4 -8 -6 -2 -7 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 4 -5 16 8 14 -29 -47 89 -8 -4 Net Fixed Assets -10 4 -1 -1 9 -10 -4 9 -8 -4 Net Investments 4 0 16 4 34 -22 -45 0 0 3 Others 10 -9 1 5 -29 3 2 80 0 -4 Cash from Financing Activity -13 -12 -14 -14 -27 20 -8 -30 -2 -1 Net Cash Inflow / Outflow 12 1 20 2 -9 -4 -43 65 -5 6 Opening Cash & Equivalents 31 29 9 7 24 28 68 3 8 2 Closing Cash & Equivalent 42 31 29 9 15 24 24 68 3 8

Description

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Mar 08

Mar 07

Cash From Operating Activity

PBT

Adjustment

-1

-2

-5

Changes in Working Capital

-4

-10

-4

-1

-5

Cash after chg. in Working capital

Interest Paid

Tax Paid

-11

-9

-7

-6

-5

-4

-8

-6

-2

-7

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-5

-29

-47

-8

-4

Net Fixed Assets

-10

-1

-10

-4

-8

-4

Net Investments

-22

-45

Others

-9

-29

-4

Cash from Financing Activity

-13

-12

-14

-27

-8

-30

-2

-1

Net Cash Inflow / Outflow

-9

-4

-43

-5

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 55 50 44 40 41 36 33 30 28 34 ROA 13% 14% 13% 15% 16% 13% 12% 10% 10% 8% ROE 16% 18% 16% 18% 20% 17% 16% 14% 14% 11% ROCE 23% 25% 27% 29% 31% 26% 23% 20% 19% 14% Fixed Asset Turnover 7.04 7.44 7.06 6.45 5.98 5.89 4.52 4.51 3.94 3.35 Receivable days 41 44 46 45 50 53 64 52 32 37 Inventory Days 27 18 17 15 14 15 17 21 23 27 Payable days 49 48 51 36 21 19 25 27 23 39 Cash Conversion Cycle 19 14 11 24 43 49 56 46 32 25 Total Debt/Equity 0.00 0.00 0.00 0.02 0.00 0.00 0.06 0.14 0.27 0.26 Interest Cover 103 172 81 61 174 44 13 8 7 31

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

13%

14%

13%

15%

16%

13%

12%

10%

ROE

16%

18%

16%

18%

20%

17%

16%

14%

11%

ROCE

23%

25%

27%

29%

31%

26%

23%

20%

19%

14%

Fixed Asset Turnover

7.04

7.44

7.06

6.45

5.98

5.89

4.52

4.51

3.94

3.35

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.00

0.02

0.00

0.06

0.14

0.27

0.26

Interest Cover

103

172

174

Description Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 08 Mar 07
Book Value (Rs.) 37 32 31 28 26 33 32 30 8 7 ROA 16% 12% 10% 8% 7% 7% 10% 116% 11% 15% ROE 20% 16% 15% 13% 11% 10% 12% 155% 20% 28% ROCE 32% 26% 22% 18% 16% 14% 20% 155% 30% 42% Fixed Asset Turnover 4.40 4.00 3.17 3.14 2.72 2.48 3.41 2.73 2.61 2.91 Receivable days 51 55 65 58 36 37 45 40 27 28 Inventory Days 16 18 23 29 29 29 25 28 39 34 Payable days 21 20 25 31 26 39 48 35 36 35 Cash Conversion Cycle 47 53 64 57 39 27 22 32 30 26 Total Debt/Equity 0.02 0.03 0.09 0.18 0.28 0.30 0.01 0.00 0.33 0.33 Interest Cover 76 35 12 7 6 28 71 240 10 15

Description

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Mar 09

Mar 08

Mar 07

Book Value (Rs.)

ROA

16%

12%

10%

116%

11%

15%

ROE

20%

16%

15%

13%

11%

10%

12%

155%

20%

28%

ROCE

32%

26%

22%

18%

16%

14%

20%

155%

30%

42%

Fixed Asset Turnover

4.40

4.00

3.17

3.14

2.72

2.48

3.41

2.73

2.61

2.91

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.02

0.03

0.09

0.18

0.28

0.30

0.01

0.00

0.33

Interest Cover

240

Amrutanjan Health Care Ltd.

Household & Personal Products

BSE: 590006 | NSE: AMRUTANJAN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Amrutanjan Health Care Ltd.

Household & Personal Products

BSE: 590006 | NSE: AMRUTANJAN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update